Compare ICCC & MATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ICCC | MATH |
|---|---|---|
| Founded | 1982 | 2015 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.5M | 145.4M |
| IPO Year | 1987 | N/A |
| Metric | ICCC | MATH |
|---|---|---|
| Price | $5.44 | $2.93 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 18.3K | ★ 113.9K |
| Earning Date | 11-13-2025 | 12-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | 0.26 | ★ 0.41 |
| Revenue | $27,769,304.00 | ★ $44,567,257.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $19.37 | ★ $6.56 |
| Revenue Growth | 16.49 | ★ 165.86 |
| 52 Week Low | $4.10 | $0.88 |
| 52 Week High | $7.60 | $4.17 |
| Indicator | ICCC | MATH |
|---|---|---|
| Relative Strength Index (RSI) | 51.37 | 50.27 |
| Support Level | $4.72 | $2.68 |
| Resistance Level | $5.36 | $3.03 |
| Average True Range (ATR) | 0.32 | 0.23 |
| MACD | 0.07 | 0.01 |
| Stochastic Oscillator | 85.08 | 61.59 |
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and generates majority of its revenue from Hong Kong.